KCNIP3 and drug-induced dyskinesia: In a mouse model of PD, DREAM deficiency exacerbates the accumulation of ∆FosB and the severity of LID, whereas overexpression of a dominant-active DREAM mutant reduces both ∆FosB expression and dyskinesia (Ruiz-DeDiego et al. 2015a).